Biden administration panned for sidestepping advisory panel to allow fourth COVID-19 shot

Not all public health experts questioned the move. University of California, Irvine, [associate] professor Andrew Noymer said he wasn’t sure why the FDA may have bypassed the panel but added that it wasn’t a “red flag” for him. “I think it makes sense to authorize a fourth dose,” he said. “It means that anyone who wants to get one can get one without breaking the rules, and it means insurance companies can cover it.”